Dapagliflozin in Heart Failure With Mildly Reduced or Preserved Ejection Fraction According to Polypharmacy Status

Alexander Peikert, Parag Goyal, Muthiah Vaduganathan, Brian L. Claggett, Ian J. Kulac, Zi Michael Miao, Orly Vardeny, Mikhail N. Kosiborod, Akshay S. Desai, Pardeep S. Jhund, Carolyn S.P. Lam, Silvio E. Inzucchi, Felipe A. Martinez, Rudolf A. de Boer, Adrian F. Hernandez, Sanjiv J. Shah, Magnus Petersson, Anna Maria Langkilde, John J.V. McMurray, Scott D. Solomon

Open source

DOI: 10.1016/j.jchf.2023.05.014
Published: 2023-10
Container: JACC: Heart Failure
Publisher: Elsevier BV
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.jchf.2023.05.014,
  title = {Dapagliflozin in Heart Failure With Mildly Reduced or Preserved Ejection Fraction According to Polypharmacy Status},
  author = {Alexander Peikert and Parag Goyal and Muthiah Vaduganathan and Brian L. Claggett and Ian J. Kulac and Zi Michael Miao and Orly Vardeny and Mikhail N. Kosiborod and Akshay S. Desai and Pardeep S. Jhund and Carolyn S.P. Lam and Silvio E. Inzucchi and Felipe A. Martinez and Rudolf A. de Boer and Adrian F. Hernandez and Sanjiv J. Shah and Magnus Petersson and Anna Maria Langkilde and John J.V. McMurray and Scott D. Solomon},
  year = {2023},
  journal = {JACC: Heart Failure},
  doi = {10.1016/j.jchf.2023.05.014},
  url = {https://doi.org/10.1016/j.jchf.2023.05.014}
}

RIS

TY  - JOUR
TI  - Dapagliflozin in Heart Failure With Mildly Reduced or Preserved Ejection Fraction According to Polypharmacy Status
AU  - Alexander Peikert
AU  - Parag Goyal
AU  - Muthiah Vaduganathan
AU  - Brian L. Claggett
AU  - Ian J. Kulac
AU  - Zi Michael Miao
AU  - Orly Vardeny
AU  - Mikhail N. Kosiborod
AU  - Akshay S. Desai
AU  - Pardeep S. Jhund
AU  - Carolyn S.P. Lam
AU  - Silvio E. Inzucchi
AU  - Felipe A. Martinez
AU  - Rudolf A. de Boer
AU  - Adrian F. Hernandez
AU  - Sanjiv J. Shah
AU  - Magnus Petersson
AU  - Anna Maria Langkilde
AU  - John J.V. McMurray
AU  - Scott D. Solomon
PY  - 2023
JO  - JACC: Heart Failure
DO  - 10.1016/j.jchf.2023.05.014
UR  - https://doi.org/10.1016/j.jchf.2023.05.014
ER  -

APA

Peikert, A., Goyal, P., Vaduganathan, M., Claggett, B. L., Kulac, I. J., Miao, Z. M., Vardeny, O., Kosiborod, M. N., Desai, A. S., Jhund, P. S., Lam, C. S., Inzucchi, S. E., Martinez, F. A., Boer, R. A. D., Hernandez, A. F., Shah, S. J., Petersson, M., Langkilde, A. M., McMurray, J. J., & Solomon, S. D. (2023). Dapagliflozin in Heart Failure With Mildly Reduced or Preserved Ejection Fraction According to Polypharmacy Status. JACC: Heart Failure. https://doi.org/10.1016/j.jchf.2023.05.014

Source records

crossref · retrieved 2026-09-27T05:52:00.404Z